• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病血管并发症的分子复杂性——全面综述。

Molecular complexities underlying the vascular complications of diabetes mellitus - A comprehensive review.

机构信息

Department of Physiology, HeartOtago, University of Otago, Dunedin, New Zealand.

Centre for Bioengineering and Nanomedicine (Dunedin), University of Otago, Dunedin, New Zealand.

出版信息

J Diabetes Complications. 2020 Aug;34(8):107613. doi: 10.1016/j.jdiacomp.2020.107613. Epub 2020 May 4.

DOI:10.1016/j.jdiacomp.2020.107613
PMID:32505477
Abstract

Diabetes is a chronic disease, characterized by hyperglycemia, which refers to the elevated levels of glucose in the blood, due to the inability of the body to produce or use insulin effectively. Chronic hyperglycemia levels lead to macrovascular and microvascular complications. The macrovascular complications consist of peripheral artery disease (PAD), cardiovascular diseases (CVD) and cerebrovascular diseases, while the microvascular complications comprise of diabetic microangiopathy, diabetic nephropathy, diabetic retinopathy and diabetic neuropathy. Vascular endothelial dysfunction plays a crucial role in mediating both macrovascular and microvascular complications under hyperglycemic conditions. In diabetic microvasculature, the intracellular hyperglycemia causes damage to the vascular endothelium through - (i) activation of four biochemical pathways, namely the Polyol pathway, protein kinase C (PKC) pathway, advanced glycation end products (AGE) pathway and hexosamine pathway, all of which commutes glucose and its intermediates leading to overproduction of reactive oxygen species, (ii) dysregulation of growth factors and cytokines, (iii) epigenetic changes which concern the changes in DNA as a response to intracellular changes, and (iv) abnormalities in non-coding RNAs, specifically microRNAs. This review will focus on gaining an understanding of the molecular complexities underlying the vascular complications in diabetes mellitus, to increase our understanding towards the development of new mechanistic therapeutic strategies to prevent or treat diabetes-induced vascular complications.

摘要

糖尿病是一种慢性疾病,其特征是高血糖,即由于身体无法有效产生或利用胰岛素,导致血液中的葡萄糖水平升高。慢性高血糖水平会导致大血管和微血管并发症。大血管并发症包括外周动脉疾病(PAD)、心血管疾病(CVD)和脑血管疾病,而微血管并发症包括糖尿病性微血管病变、糖尿病肾病、糖尿病性视网膜病变和糖尿病性神经病变。血管内皮功能障碍在高血糖条件下介导大血管和微血管并发症中起着至关重要的作用。在糖尿病性微血管中,细胞内高血糖通过以下方式对血管内皮造成损害:(i)四种生化途径的激活,即多元醇途径、蛋白激酶 C(PKC)途径、晚期糖基化终产物(AGE)途径和己糖胺途径,所有这些途径都将葡萄糖及其中间产物转化为活性氧的过度产生;(ii)生长因子和细胞因子的失调;(iii)表观遗传变化,即 DNA 作为对细胞内变化的响应而发生的变化;以及(iv)非编码 RNA,特别是 microRNAs 的异常。本综述将重点探讨理解糖尿病血管并发症背后的分子复杂性,以增加我们对开发新的机制治疗策略以预防或治疗糖尿病引起的血管并发症的理解。

相似文献

1
Molecular complexities underlying the vascular complications of diabetes mellitus - A comprehensive review.糖尿病血管并发症的分子复杂性——全面综述。
J Diabetes Complications. 2020 Aug;34(8):107613. doi: 10.1016/j.jdiacomp.2020.107613. Epub 2020 May 4.
2
Pathophysiological mechanisms of diabetic angiopathy.糖尿病血管病变的病理生理机制。
J Diabetes Complications. 2003 Mar-Apr;17(2 Suppl):16-9. doi: 10.1016/s1056-8727(02)00275-1.
3
Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy.糖尿病血管并发症:病理生理学、生化基础及潜在治疗策略。
Curr Pharm Des. 2005;11(18):2279-99. doi: 10.2174/1381612054367300.
4
The role of protein kinase C activation and the vascular complications of diabetes.蛋白激酶C激活的作用与糖尿病的血管并发症
Pharmacol Res. 2007 Jun;55(6):498-510. doi: 10.1016/j.phrs.2007.04.016. Epub 2007 May 5.
5
The cellular and molecular mechanisms of diabetic complications.糖尿病并发症的细胞和分子机制。
Endocrinol Metab Clin North Am. 1996 Jun;25(2):255-70. doi: 10.1016/s0889-8529(05)70324-8.
6
Molecular mechanisms of diabetic vascular complications.糖尿病血管并发症的分子机制
J Diabetes Investig. 2010 Jun 1;1(3):77-89. doi: 10.1111/j.2040-1124.2010.00018.x.
7
The prognostic value of inflammatory and vascular endothelial dysfunction biomarkers in microvascular and macrovascular complications in type 1 diabetes.炎症和血管内皮功能障碍生物标志物在1型糖尿病微血管和大血管并发症中的预后价值。
Pediatr Endocrinol Diabetes Metab. 2019;25(1):28-35. doi: 10.5114/pedm.2019.84710.
8
A Review on Cellular and Molecular Mechanisms Linked to the Development of Diabetes Complications.糖尿病并发症发生发展相关细胞与分子机制综述
Curr Diabetes Rev. 2021;17(4):457-473. doi: 10.2174/1573399816666201103143818.
9
The missing link: a single unifying mechanism for diabetic complications.缺失的环节:糖尿病并发症的单一统一机制
Kidney Int Suppl. 2000 Sep;77:S26-30. doi: 10.1046/j.1523-1755.2000.07705.x.
10
Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases.高血糖诱导的氧化应激及其在糖尿病相关心血管疾病中的作用。
Curr Pharm Des. 2013;19(32):5695-703. doi: 10.2174/1381612811319320005.

引用本文的文献

1
Peripheral Arterial Disease is Associated with Sensorimotor Peripheral Neuropathy in People with Type 2 Diabetes.外周动脉疾病与2型糖尿病患者的感觉运动性外周神经病变相关。
Med J Islam Repub Iran. 2024 Dec 7;38:143. doi: 10.47176/mjiri.38.143. eCollection 2024.
2
A comparative study of internal fixation with porous tantalum screws and cannulated screws in the treatment of femoral neck fractures.多孔钽金属螺钉与空心螺钉内固定治疗股骨颈骨折的对比研究
Sci Rep. 2025 Jun 4;15(1):19508. doi: 10.1038/s41598-025-04188-w.
3
Sweeteners: erythritol, xylitol and cardiovascular risk-friend or foe?
甜味剂:赤藓糖醇、木糖醇与心血管风险——是友还是敌?
Cardiovasc Res. 2025 Aug 14;121(9):1319-1329. doi: 10.1093/cvr/cvaf091.
4
Discovering diabetes complications-related microRNAs: meta-analyses and pathway modeling approach.发现与糖尿病并发症相关的微小RNA:荟萃分析和通路建模方法。
BMC Med Genomics. 2025 May 15;18(1):86. doi: 10.1186/s12920-025-02144-1.
5
Diabetes Mellitus and Associated Vascular Disease: Pathogenesis, Complications, and Evolving Treatments.糖尿病及相关血管疾病:发病机制、并发症与不断发展的治疗方法
Adv Ther. 2025 Jun;42(6):2659-2678. doi: 10.1007/s12325-025-03185-9. Epub 2025 Apr 19.
6
A Narrative Review: Relationship Between Glycemic Variability and Emerging Complications of Diabetes Mellitus.一篇叙述性综述:血糖变异性与糖尿病新出现并发症之间的关系
Biomolecules. 2025 Jan 28;15(2):188. doi: 10.3390/biom15020188.
7
Discovery of Hydrazine Clubbed Thiazoles as Potential Antidiabetic Agents: Synthesis, Biological Evaluation, and Molecular Docking Studies.肼基噻唑类化合物作为潜在抗糖尿病药物的发现:合成、生物学评价及分子对接研究
Drug Dev Res. 2025 Feb;86(1):e70060. doi: 10.1002/ddr.70060.
8
Unlocking the mechanistic potential of for managing diabetic neuropathy and nephropathy.挖掘[具体药物或治疗手段等,原文此处缺失关键信息]在治疗糖尿病神经病变和肾病方面的潜在作用机制。
J Tradit Complement Med. 2024 Apr 24;14(6):581-597. doi: 10.1016/j.jtcme.2024.04.009. eCollection 2024 Nov.
9
Diagnosis, Pathophysiology and Management of Microvascular Dysfunction in Diabetes Mellitus.糖尿病微血管功能障碍的诊断、病理生理学及管理
Diagnostics (Basel). 2024 Dec 16;14(24):2830. doi: 10.3390/diagnostics14242830.
10
Erectile dysfunction and associated factors among patients with diabetes in Public hospitals of Harari region, Eastern Ethiopia: modified poisson regression model.埃塞俄比亚东部哈拉里地区公立医院糖尿病患者的勃起功能障碍及其相关因素:修正泊松回归模型
BMC Endocr Disord. 2024 Dec 21;24(1):275. doi: 10.1186/s12902-024-01815-x.